Saturday 17 October 2026 Export ORGO’s income statement to Excel — free account

Organogenesis

ORGO Healthcare Drug Manufacturers Specialty & Generic

Organogenesis' revenue for fiscal 2025 (year ended December 2025) was $564.2 million, up 17.0% from fiscal 2024. In the quarter to June 2026, revenue fell 56.7%, EPS fell 670.0%, free cash flow grew 10.3% and total debt rose 10,940.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.99 0.12 −10.81%

Follow ORGO

Alert me

Market cap: $142.8M
P/E: 0.0×
Fwd P/E: −2.6×
Dividend yield: —
F-score: 4/9
Altman Z: 3.03
Beneish M: −1.41
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	4	5	4	3	+8 more TTM periods Free account
ROE Full definition →	(53.31%)	(5.97%)	7.11%	(5.02%)
ROA Full definition →	(23.44%)	(2.95%)	3.65%	(2.80%)
ROIC Full definition →	(19.97%)	0.97%	12.78%	(2.71%)
Return on Tangible Assets Full definition →	(41.53%)	(4.90%)	5.47%	(4.66%)
Average Days of Receivables Full definition →	80.54	82.90	140.68	132.42
Free Cash Flow per Share Full definition →	0.16	0.13	(0.19)	(0.41)
Free Cash Flow Full definition →	20.84	17.08	(24.46)	(51.65)
Capital Expenditures Full definition →	(11.13)	(13.67)	(14.15)	(12.86)
Other line items
Cash ROIC Full definition →	10.12%	4.89%	(6.01%)	(16.06%)
Accounts Receivable Turnover Full definition →	4.13	4.67	3.45	3.45
Accounts Payable Turnover Full definition →	4.60	5.24	4.52	3.70
Inventory Turnover Full definition →	4.35	4.83	4.93	3.56
Average Days of Payables Full definition →	78.84	74.83	84.80	123.72
Days of Inventory on Hand Full definition →	78.81	74.34	78.63	121.76
Tax Rate Full definition →	1.42	(0.36)	(0.21)	(1.16)
Research and Development Expense of Revenue Full definition →	12.45%	9.53%	7.90%	9.84%
Selling, General and Administrative Expense of Revenue Full definition →	65.38%	61.96%	57.83%	64.47%
Share Based Compensation of Revenue Full definition →	3.08%	2.64%	2.36%	2.55%
Operating CF/Net income Full definition →	(0.31)	(2.11)	(0.51)	2.90
Depreciation/Fixed assets Full definition →	0.32	0.32	0.26	0.34
Capex/Depreciation Full definition →	(0.34)	(0.41)	(0.53)	(0.49)
Revenue per Share Full definition →	3.56	4.03	4.45	3.67
Operating CF per Share Full definition →	0.25	0.24	(0.08)	(0.31)
Capex per Share Full definition →	(0.09)	(0.11)	(0.11)	(0.10)
Capex to Sales Full definition →	0.02	0.03	0.03	0.03

Show all line items

Columns are period end dates

Stockrow Weekly